Benjamin Rosen, PhD

 Benjamin S. Rosen
Program Director
Medical Physics Residency
Clinical Associate Professor of Radiation Oncology
Medical School
Michigan Medicine
Internal Medicine-Hematology/Oncology
1500 E Medical Center Dr
Ann Arbor, MI 48109
[email protected]
Available to mentor
Benjamin Rosen, PhD
Benjamin S. Rosen
Clinical Associate Professor
  • About
  • Links
  • Qualifications
  • Research Overview
  • Recent Publications

  • Manage Your Profile

    • About

    Dr. Benjamin Rosen is an Associate Professor and the Medical Physics Residency Program Director within the Department of Radiation Oncology at Michigan Medicine. He received his PhD from the University of Wisconsin in 2015 with thesis entitled, "Advanced radiochromic film methodologies for quantitative dosimetry of small and nonstandard fields". Dr. Rosen was an Academic Clinical Medical Physics Resident at Michigan Medicine from 2015-2018 and has worked on numerous nationally funded research projects and taught many learners in Ann Arbor and beyond.

    Links
    • RadOnc Bio

    Qualifications
    • Resident
      University of Michigan Medical School, Physics, Ann Arbor, United States
      2015 - 2017
      Residency
    • PhD
      University of Wisconsin - Madison, Madison, WI, United States
      2012 - 2015
    • MS
      University of Wisconsin - Madison, Madison, WI, United States
      2010 - 2012
    • BS
      University of Texas at Austin, Austin, TX, United States
      2004 - 2008

    Research Overview

    - Advanced imaging analysis to support adaptive radiotherapy in head and neck, brain, and liver tumors and surrounding normal tissues.
    - Building predictive models for risk assessments of tumor control and normal tissue complication for various treatment combinations, including immune checkpoint inhibition therapy in combination with stereotactic ablative body radiotherapy.
    - Investigations of normal tissue tolerance and treatment efficacy in the re-irradation setting

    Recent Publications

     See All Publications
    • Journal Article
      The Reality of Cumulative Dose.
      Paradis KC, Rosen BS. Int J Radiat Oncol Biol Phys, 2026 Mar 15; 124 (4): 895 DOI:10.1016/j.ijrobp.2025.12.003
      PMID: 41741091
    • Journal Article
      Constraints, cumulative doses and toxicity outcomes in glioma reirradiation: a systematic review and radiobiological comparison from the Reirradiation Collaborative Group (ReCog).
      Slevin F, Chen XS, Rosen BS, Shen CJ, Mayo C, Zhang L, Butala AA, Ajithkumar T, Kim MM, Murray L. Int J Radiat Oncol Biol Phys, 2026 Mar 12; DOI:10.1016/j.ijrobp.2026.03.004
      PMID: 41831790
    • Additional Scholarship
      Data from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17; DOI:10.1158/1078-0432.c.8313715
    • Journal Article
      FDG-PET-Based Selective Deescalation of Chemoradiation in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. Clinical Cancer Research an Official Journal of the American Association for Cancer Research, 2026 Feb 17; 32 (4): 684 - 693. DOI:10.1158/1078-0432.CCR-25-2820
      PMID: 41385605
    • Additional Scholarship
      Supplementary Data 1 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17; DOI:10.1158/1078-0432.31353226
    • Additional Scholarship
      Supplementary Figure 1 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17; DOI:10.1158/1078-0432.31353223
    • Additional Scholarship
      Supplementary Figure 2 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17; DOI:10.1158/1078-0432.31353220
    • Additional Scholarship
      Supplementary Figure 3 from FDG-PET–Based Selective Deescalation of Chemoradiation in Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma: A Multicenter Phase II Trial
      Mierzwa M, Rosen B, Suresh K, Dinesh A, Regan S, Brummel C, Wong K, Casper K, Prince M, Malloy K, Shuman A, Chinn S, Cao Y, Aryal M, Heft-Neal M, Stucken C, Buchakjian M, Forner D, Yalamanchi P, Swiecicki P, Lawrence TS, Akhdar R, Tewari M, Bhambhani C, Walline H, Brenner JC, Shah J, Worden F. 2026 Feb 17; DOI:10.1158/1078-0432.31353217